Targeting extrinsic apoptosis in cancer: Challenges and opportunities

Simone Fulda1

  • 1Institute for Experimental Cancer Research in Pediatrics, Goethe-University, Komturstr. 3a, 60528 Frankfurt, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.

Insights

Targeting apoptosis, a crucial programmed cell death process, offers a promising strategy for novel cancer therapies. Understanding apoptosis signaling in cancer can lead to more effective cancer treatments.

Area of Science:

  • Molecular Biology
  • Cell Biology
  • Oncology

Background:

  • Apoptosis, or programmed cell death, is vital for normal physiological and pathological processes.
  • Dysregulation of apoptosis is a hallmark of human cancers.
  • Current cancer therapies often leverage apoptosis signaling pathways for antitumor effects.

Purpose of the Study:

  • To highlight the significance of apoptosis in cancer.
  • To emphasize the potential of targeting apoptosis for cancer therapy.
  • To underscore the need for deeper understanding of apoptosis signaling in cancer.

Main Methods:

  • Review of existing literature on apoptosis and cancer.
  • Analysis of signaling pathways involved in apoptosis.
  • Examination of therapeutic strategies targeting apoptosis.

Main Results:

  • Apoptosis plays a critical role in cancer development and progression.
  • Targeting apoptosis pathways is a viable strategy for novel anticancer drug development.
  • Understanding signaling networks is key to improving apoptosis-based cancer treatments.

Conclusions:

  • Therapeutic targeting of apoptosis is a promising approach for cancer treatment.
  • Further research into apoptosis signaling in cancer will drive the development of new therapies.
  • Apoptosis-targeted therapies hold significant potential for improving patient outcomes.

Related Concept Videos

The Extrinsic Apoptotic Pathway01:17

The Extrinsic Apoptotic Pathway

The extrinsic apoptotic pathway is initiated when extracellular death-inducing signals, such as specific cytokines, activate the death receptors expressed on the cell surface. The immune cells involved in this pathway are natural killer cells (NK cells) and cytotoxic T-lymphocytes. NK cells are critical in innate immune response, while cytotoxic T-lymphocytes are associated with adaptive immune response. These cells recognize specific receptors expressed on the altered cells and activate...
9.5K
The Intrinsic Apoptotic Pathway01:31

The Intrinsic Apoptotic Pathway

Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
9.3K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K
Apoptosis01:30

Apoptosis

Apoptosis is a combination of two Greek words, 'apo' and 'ptosis,' meaning separation and falling off, respectively. Hippocrates used this word to describe gangrene, which was caused due to bandaging of fractured bones. Apoptosis was distinguished from necrosis in 1970 when John Kerr reported observations of morphological changes occurring during apoptosis. During one experiment, he observed that the disruption of blood supply to the liver tissue resulted in a size...
17.3K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
6.4K